Caas Capital Management LP Medtronic PLC Call Options Transaction History

Caas Capital Management LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	SELL	$78.22 - $90.4 $242,482 - $280,240	-3,100 Reduced 56.36%	2,400 $188,000
Q2 2023 Aug 14, 2023	SELL	$79.47 - $91.38 $262,251 - $301,554	-3,300 Reduced 37.5%	5,500 $484,000
Q1 2023 May 15, 2023	SELL	$76.72 - $87.58 $1.66 Million - $1.89 Million	-21,600 Reduced 71.05%	8,800 $709,000
Q4 2022 Feb 14, 2023	BUY	$76.18 - $87.74 $2.32 Million - $2.67 Million	30,400 New	30,400 $2.36 Million
Q1 2022 May 13, 2022	SELL	$100.58 - $112.38 $25.4 Million - $28.4 Million	-252,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$99.53 - $127.75 $288,637 - $370,475	2,900 Added 1.16%	252,900 $26.2 Million
Q1 2021 May 17, 2021	BUY	$111.18 - $119.74 $27.8 Million - $29.9 Million	250,000 New	250,000 $29.5 Million

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.